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Abstract 
Several researches have evidenced that cancer cells can produce volatile organic compounds (VOCs) which are released 
not only in breath but also in other organic fluids, such as blood and urine. This study has evaluated the olfactory 
capability of trained dogs to detect human lung cancer VOCs in urine. We recruited 150 subjects from European Institute 
of Oncology (IEO) divided into three groups: 57 patients with lung cancer (group 1); 38 patients with lung disease, other 
than cancer (group 2); 55 healthy control subjects (group 3).The results are referred to the last 45 days of training, and 
evidenced that dogs reached a mean success rate that exceeded 80%, with a sensitivity of 0,72 and a specificity of 0,94 for 
two out of three dogs enrolled. The important novelty is that dogs can discriminate lung cancer not only from healthy 
subjects, but also from patients with other lung diseases. The results obtained so far are encouraging and lead us to 
persevere with the training session in order to improve the success rate, reaching values as close as possible to 100%. If 
so, we believe that, in the future, dogs may be used to perform early diagnostic tests, useful in improving the chances of 
survival in cases of human lung cancer. 
 
Introduction 
     Lung cancer (Lc) in humans is the leading cause of 
cancer-related deaths in the world. The 5 years survival 
rate is 54% for cases diagnosed when the disease is still 
localized, but only 15% of lung cancers are identified at 
this early stage [1], due to the limited capabilities of 
existing diagnostic methods. Therefore, early detection of 
lung cancer is a desirable goal, because it often permits an 
improvement of the prognosis and a longer survival. In 
1985, Gordon SM et al. have demonstrated that lung 
cancer cell lines can produce specific volatile organic 
compounds (VOCs) which are released into breath [2]. 
Some of these VOCs are likely to have distinctive odors 
which can provide information for diagnostic purposes 
[2]. Actually, the domestic dog is widely considered as a 
fast, mobile and relatively accurate detection system 
available for locating odorous substances. This suggests 
that dogs can provide a contribution also in the field of 
oncology. Even when present in minute quantities, VOCs 
are believed to be detectable by dogs, with their 
exceptional olfactory acuity [3,4]. In 2004, Willis CM et al. 
[5] published the first paper showing that dogs can detect 
bladder cancer by olfactory means, and afterwards, a 
number of studies examining the utility of analyzing VOCs 
in exhaled breath using dogs have been carried out and 
have shown promising - but still not definite - results 
[6,7]. Unfortunately, collecting, handling, storing, 
concentrating and analyzing breath samples are 
troublesome and technically challenging. A partial 
solution to these problems would be the use of a much 
more convenient source of volatiles, such as urine 
samples. Based on this consideration, Matsumura et al. [8] 
were able to identify volatile chemical signatures in urine 
of mouse models of lung cancer using rigorous 
experimental behavioral and analytic techniques, 
establishing the feasibility of using urinary volatiles to 
detect lung cancer. 
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Our study aimed to train dogs for human lung cancer 
related VOC detection in urine, in order to make an early 
diagnosis and to improve the prognosis, contributing to 
reduce cancer mortality. 
 
Materials and Methods 
Subjects 
     Human volunteers were recruited by European 
Institute of Oncology (IEO). Eligible patients were men 
and women aged between 50 and 80 years old, healthy or 
with a recent conventional diagnosis of lung cancer or 
other types of pulmonary disease. In case of lung cancer, 
patients were referred immediately after definitive 
diagnosis, to avoid potential chemotherapy-induced 
alteration of the profile of urinary VOCs. None of the 
patients had a previous historyof cancer within five years. 
 
     Healthy subjects, with the same age range, were 
selected as the control group. None of them had a referred 
history of clinically significant pulmonary disease. In 
order to confirm the absence of oncological findings, they 
were required to have had a recent (within the previous 
6months) negative chest x-ray or CT scan. 
 
     Drugs, menstrual cycle, ethnicity, diet, alcohol 
consumption, smoking habits and exposure to chemicals 
were not considered exclusion criteria. However, these 
factors were recorded in order to analyze their possible 
influence on dog’s signaling. All volunteers were provided 
with appropriate information concerning the study and a 
written informed consent were obtained from them all. 
 
Subjects were divided into three groups:  
Group 1) patients with lung cancer (n. 57) 
Group 2) patients with lung disease, other than cancer (n. 
38)  
Group 3) healthy control subjects (n. 55). 
 
Sampling of urine 
     Each volunteer donated at least 20 ml of urine, which 
was placed in a sterile container. Urine samples were 
refrigerated within 45 min and frozen 2-32 hours later, as 
1 ml aliquots in hermetically sealed tubes. As reported in 
literature [6], these samples can be stored at -40°C for up 
to five months. For presentation to the dogs, samples 
were defrosted and immediately used, in a wet state. 
 
Dog training 
     We employed three family dogs: two female Belgian 
Malino is shepherd dogs, Bloom and Dixie, 3 and 5 years 
old respectively, and a 3-year-old female mixed breed 
dog, Helix. They were trained by clicker training method 
(operant conditioning) with positive reinforcement 
(food). 
 
     During training, animals worked with samples taken 
from patients of all three groups. Training sessions were 
held twice a week, in a dedicated facility of the Veterinary 
Department of the University of Milan, where no other 
animal had access, in order to avoid odor bias. The room 
was well aerated and conditioned to maintain optimal 
temperature and humidity conditions, therefore avoiding 
climate interference.  
 
     The six sample stations, designed and constructed of 
stainless steel, were positioned in a single straight line as 
in Figure 1. The training consisted of two sessions of six 
runs. In each run, samples tubes were selected to 
compose six-slot panels so that 1 sample of Group 1 and 
at least 1 sample of Group 2 were compared with samples 
of healthy subjects, possibly varying the identity of the 
donors. The positions of the samples were randomly 
changed throughout the successive trials; thus, the dog’s 
choices could not be driven by any memory interference. 
Moreover, since each dog carried out two sessions per 
day, at the end of each session the six-slot panels were 
changed and the sample station perfectly cleaned with a 
vapor machine. Dogs were asked to indicate the correct 
responses by sitting directly in front of the station 
containing the cancer sample. 
 
 
Figure 1: Bloom sitting in front of a positive sample. 
The six sample stations, of stainless steel, were 
positioned in a single straight line. 
 
     All the sessions were videotaped, for accurate analysis 
of canine responses and behavior. High standards of 
ethics were respected in study design and conduction, to 
guarantee dog’s psychophysical wellbeing. 
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Statistical Analysis and Results 
     We decided to analyze the last 45 days of training, i.e. 
the last six months, during which the dog handler was 
blinded to knowledge of the target sample. Statistical 
analysis was performed using IBM SPSS Statistics for 
Windows, version 22.0 (Armonk, NY: IBM Corp). The 
primary outcome measure was the mean ± S.E proportion 
of successes for each dog. The Kruskal-Wallis test was 
used to detect statistically significant differences in the 
success rates of the three dogs throughout the entire 
training cycle. 
 
     Diagnostic accuracy was calculated as sensitivity and 
specificity of the dog’s indication of samples compared 
with the true diagnosis confirmed by TAC. Thus, the 
sensitivity refers to the conditional probability of the dog 
indicating cancer when the condition was present and 
specificity refers to the conditional probability of the dog 
ignoring a sample from a healthy donor. Both sensitivity 
and specificity were expressed as proportions. Point 
estimates were calculated with 95% confidence intervals. 
The probability of a perfect test run (finding the right 
sample and ignoring the controls) by chance was 1/6 
(17%). All statistical tests were 2-sided with exact p<0.05 
considered statistically significant. In Figure 2 is reported 
all dog’s mean success rate, during the last 45 days of 
training, which shows an improvement trend that exceeds 
80% at the end of the period considered. Dogs’ sensitivity 
and specificity are reported in Table 1. “DOG ID” was a 
significant positive predictor for successful outcomes 
(Table 2). As shown by the Exp (B) coefficient in the 
logistic regression, both Bloom and Helix were about 2.5 
times more likely to correctly locate the cancer sample 
and ignoring all 5 control samples. 
 
 
Figure 2: Dog’s mean success rate trend during training. 
 
Dog ID Estimate 
95% 
Lower Upper 
Bloom 
Sensitivity 0,782 0,670 0,899 
Specificity 0,956 0,908 1,011 
Helix 
Sensitivity 0,650 0,515 0,785 
Specificity 0,930 0,857 1,002 
Dixie 
Sensitivity 0,595 0,452 0,748 
Specificity 0,362 0,838 1,002 
Table 1: Diagnostic test accuracy. 
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Factors P Exp(B) 95% CI for Exp(B) 
Hosmer-Lemeshow 
significance test 
Dog (Bloom) 0,001 2,598 
Lower Upper 
0,240 
1,887 3,876 
Dog (Helix) 0,001 2,395 1,808 3,172 
 
Table 2: Logistic regression models predicting correct discrimination. 
Only factors for which a statistically significant difference emerged are reported. 
Significance, P<0.05. Exp(B), Exponentiation of the B coefficient (odds ratio). 
CI, confidence interval. 
 
Discussion 
     Lung cancer continues to represent a heavy burden for 
health care systems worldwide. This study evidenced that 
Lc gives a VOC-related odor signature to urine, which can 
be detected by dogs. This preliminary result shows that 
canine olfactory capability may be considered a valid 
diagnostic method for early detection of Lc in humans, 
with the advantage of being a fast, non-invasive, painless 
and inexpensive method. Moreover, to the best of our 
knowledge, this is the first study evidencing that dogs can 
discriminate urine of patients with lung cancer not only 
from healthy subjects, but also from patients with other 
types of pulmonary disease.  
 
     The hypothesis that dogs may be able to detect cancer 
in humans on the basis of specific odor find its roots in 
1989, when Williams and Pembroke described, for the 
first time, the case of a 44-year-old woman who became 
aware of a melanoma on her left thigh after her untrained 
female dog began sniffing intensely and repeatedly at the 
lesion through her clothing [9]. Since then, similar 
anecdotal events have been reported. Although 
unsupported by experimental evidence, they had the 
merit of drawing medical community’s attention to the 
concept that dogs can “smell” cancer in patients. As time 
goes by, intriguing evidence emerged that melanoma and 
bladder cancers could be detected by dogs through their 
scenting abilities [10]. In 2003, John Church brought 
together a team of doctors, dog trainers and scientists and 
in 2004 a preliminary proof of principle study was 
completed [5]. This study provided the first piece of 
experimental evidence to show that dogs can detect 
cancer by olfactory means and was the first clinically 
robust trial to be completed and published in the world. 
 
     Since 1982, researches were also conducted to develop 
sensor arrays, commonly referred to as “electronic noses”, 
which could identify VOCs linked to cancer since early 
stages using breath samples [11-13]. However their 
applicability is limited because an optimized sample 
collection is necessary, the instruments are very sensitive 
and no lung cancer-specific VOCs have been identified to 
date [14]. Moreover, patients are required not to smoke 
and fast before breath samples are taken. Finally, it has 
been shown that measuring VOCs with electronic nose 
has not yet been standardized, and the set-up significantly 
affects the results [15]. Canine scent detection may help 
overcome some of these drawbacks, due to the 
extraordinary dog's ability to detect and discriminate a 
specific odor among a myriad of odorant components. 
 
     In our study, the dog’s mean success rate has improved 
during the training period, reaching a value that exceeded 
80%. We are confident that success rate can be further 
improved after an adequate ongoing period of training. If 
the next phases of this study will confirm these results, 
the integration of sniffer dogs into research and 
prevention strategies will turn out to be a useful tool for 
early diagnosis of lung cancer, giving the possibility to 
improve patient survival. Moreover, the ability of dogs to 
detect cancer can be usedas a friendly message to the 
public, encouraging people to undergo medical 
examination even in the absence of any signs or 
symptoms. 
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